MedPath

Airsonett AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (50.0%)
Phase 3
1 (50.0%)

Clinical Effects of Temperature Controlled Laminar Airflow (TLA)

Phase 2
Completed
Conditions
Perennial Allergy
Asthma
First Posted Date
2009-09-30
Last Posted Date
2015-01-14
Lead Sponsor
Airsonett AB
Target Recruit Count
28
Registration Number
NCT00987064
Locations
🇸🇪

University Hospital, Linkoeping, Linkoeping, Sweden

🇸🇪

Karolinska University Hospital, Stockholm, Sweden

Efficacy Study of Temperature Controlled Laminar Airflow (TLA)-Treatment in Perennial Allergic Asthma

Phase 3
Completed
Conditions
Asthma
First Posted Date
2009-09-29
Last Posted Date
2010-11-09
Lead Sponsor
Airsonett AB
Target Recruit Count
312
Registration Number
NCT00986323
Locations
🇩🇰

Aarhus University Hospital, Aarhus, Denmark

🇩🇰

Bispebjerg Hospital, Copenhagen, Denmark

🇫🇮

Turku Allergy Centre, Turku, Finland

and more 16 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.